Congress and its idiocy on drugs
Congress increasingly seems to deserve its poor reputation. Despite having some really excellent members, the body as a whole simply cannot do a decent job. Phillip Smith reports:
Going in the face of an ever-increasing clamor to reform decades of failed drug policies, the US House of Representatives is poised to pass two bills that promise more of the same. The House is set to vote any day now—the vote was originally set until Wednesday night, but was pushed back—on HR 1254, the Synthetic Drug Control Act of 2011, which would criminalize not only synthetic stimulants (“bath salts”), but also synthetic cannabinoids (“fake pot”) marketed under names such as “K2” and “Spice.”
“This is almost certain to pass,” said Grant Smith, federal affairs coordinator for the Drug Policy Alliance (DPA), which has been lobbying to try to stop it. “We’re doing our best to try to block it, but it’s unlikely we will succeed,” he said.
The bill foresees prison sentences of up to 20 years for the distribution of small quantities of synthetic drugs. But despite an intense debate in the House Judiciary Committee last month over the bill’s implications, it is moving ahead.
At least 40 states have passed bans on the new synthetic drugs, and the DEA has placed both fake weed and bath salts under emergency bans. The bill would make both sets of substances Schedule I drugs under the Controlled Substances Act, which would make them difficult to research. Scientists have warned Congress that placing synthetic drugs under Schedule I will have a chilling effect on research intended to explore treatments for a range of diseases and disorders. . .
Continue reading. Later in the article:
The second bill, HR 313, the Drug Trafficker Safe Harbor Elimination Act of 2011, introduced by veteran drug warrior Rep. Lamar Smith (R-TX) would make it a criminal offense to plan to engage in an activity in another country if that activity would violate US drug laws if committed in the US — even if that activity is legal in the country where it takes place.
While Smith and other bill supporters say the legislation is aimed at drug traffickers who conspire in the US, opponents point out that it could just as easily be applied to someone who makes plans to attend and partake at the Cannabis Cup in Amsterdam, work at a safe injection site in Vancouver or any of the other 64 cities that have them, or work in a medical marijuana program in Israel. All of those activities are illegal under federal drug laws and thus subject to the purview of the bill.
“Since the war on drugs was declared 40 years ago, the US has spent more than one trillion dollars and arrested tens of millions of Americans for drug law violations, yet drugs are readily available in every community and the problems associated with them continue to mount,” said Bill Piper, DPA director of national affairs. “When you’re in a hole, you shouldn’t just keep digging,” he added.
“Facing massive budget deficits, policymakers from both parties should be searching for alternatives to prison for nonviolent drug law offenders, because locking them up is only making us poorer, not safer,” said Piper. “The US can’t incarcerate its way out of its drug problems and should stop trying. The only way out of the drug war mess is to start treating drug use as a health issue instead of a criminal justice issue.”
“By rushing to criminalize synthetic drugs, Congress is condemning more Americans to years in prison and ignoring warnings from the scientific community that this bill will hurt medical research,” said Smith. “Outright criminalization compromises both public health and safety by shifting demand for synthetic drugs into the criminal market. It would be more effective for Congress to pursue comprehensive drug education and create a regulatory framework to reduce youth access to synthetic drugs. This approach is working for tobacco, which has contributed to more deaths than alcohol and illicit drugs combined.”